TrialAddiction (Abingdon, England)2022

HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trial.

P Todd Korthuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.